相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
Matias E. Valsecchi et al.
BMC CANCER (2012)
Cancer Statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno et al.
CELL (2012)
Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches
David A. Tuveson et al.
CELL (2012)
The Genetic Basis for Cancer Treatment Decisions
Janet E. Dancey et al.
CELL (2012)
EMT and Dissemination Precede Pancreatic Tumor Formation
Andrew D. Rhim et al.
CELL (2012)
Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
James A. McCubrey et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Oncogenic Kras is required for both the initiation and maintenance of pancreatic cancer in mice
Meredith A. Collins et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
Samuel A. Wells et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Gamma secretase inhibition promotes hypoxic necrosis in mouse pancreatic ductal adenocarcinoma
Natalie Cook et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Multimarker Gene Analysis of Circulating Tumor Cells in Pancreatic Cancer Patients: A Feasibility Study
Andreia de Albuquerque et al.
ONCOLOGY (2012)
Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue
Andrea S. Bauer et al.
PLOS ONE (2012)
nab-Paclitaxel Potentiates Gemcitabine Activity by Reducing Cytidine Deaminase Levels in a Mouse Model of Pancreatic Cancer
Kristopher K. Frese et al.
CANCER DISCOVERY (2012)
Fluorouracil-based Chemoradiation with Either Gemcitabine or Fluorouracil Chemotherapy after Resection of Pancreatic Adenocarcinoma: 5-Year Analysis of the US Intergroup/RTOG 9704 Phase III Trial
William F. Regine et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
New Approaches to the Treatment of Pancreatic Cancer From Tumor-Directed Therapy to Immunotherapy
Maeve A. Lowery et al.
BIODRUGS (2011)
Enhancing the translation of cancer biomarkers
E. Costello et al.
BRITISH JOURNAL OF SURGERY (2011)
Improving outcome for patients with pancreatic cancer through centralization
V. E. P. P. Lemmens et al.
BRITISH JOURNAL OF SURGERY (2011)
Baseline Circulating Tumor Cell Counts Significantly Enhance a Prognostic Score for Patients Participating in Phase I Oncology Trials
David Olmos et al.
CLINICAL CANCER RESEARCH (2011)
MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma
Meir Preis et al.
CLINICAL CANCER RESEARCH (2011)
Novel Approaches to Target Pancreatic Cancer
M. Porzner et al.
CURRENT CANCER DRUG TARGETS (2011)
microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma
Adam E. Frampton et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target
Chenwei Li et al.
GASTROENTEROLOGY (2011)
Stromal biology and therapy in pancreatic cancer
Albrecht Neesse et al.
GUT (2011)
Gemcitabine Plus nab-Paclitaxel Is an Active Regimen in Patients With Advanced Pancreatic Cancer: A Phase I/II Trial
Daniel D. Von Hoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Identification of serum proteins involved in pancreatic cancer cachexia
Klaus Felix et al.
LIFE SCIENCES (2011)
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
Eric A. Collisson et al.
NATURE MEDICINE (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
CD40 Agonists Alter Tumor Stroma and Show Efficacy Against Pancreatic Carcinoma in Mice and Humans
Gregory L. Beatty et al.
SCIENCE (2011)
Notch signalling in solid tumours: a little bit of everything but not all the time
Prathibha Ranganathan et al.
NATURE REVIEWS CANCER (2011)
Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma
Raphael Marechal et al.
CANCER (2010)
Molecular Predictors of Outcome in a Phase 3 Study of Gemcitabine and Erlotinib Therapy in Patients With Advanced Pancreatic Cancer National Cancer Institute of Canada Clinical Trials Group Study PA 3
Gilda da Cunha Santos et al.
CANCER (2010)
Deploying Mouse Models of Pancreatic Cancer for Chemoprevention Studies
Paul J. Grippo et al.
CANCER PREVENTION RESEARCH (2010)
MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
Elisa Giovannetti et al.
CANCER RESEARCH (2010)
AACR-FDA-NCI Cancer Biomarkers Collaborative Consensus Report: Advancing the Use of Biomarkers in Cancer Drug Development
Samir N. Khleif et al.
CLINICAL CANCER RESEARCH (2010)
MicroRNAs: Predictors and modifiers of chemo- and radiotherapy in different tumour types
Richard Hummel et al.
EUROPEAN JOURNAL OF CANCER (2010)
Estimates of cancer incidence and mortality in Europe in 2008
J. Ferlay et al.
EUROPEAN JOURNAL OF CANCER (2010)
Targeting Notch signaling in pancreatic cancer
Elodie Ristorcelli et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families
Christopher J. Grocock et al.
GUT (2010)
Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid vs Gemcitabine Following Pancreatic Cancer Resection A Randomized Controlled Trial
John P. Neoptolemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
The patterns and dynamics of genomic instability in metastatic pancreatic cancer
Peter J. Campbell et al.
NATURE (2010)
Distant metastasis occurs late during the genetic evolution of pancreatic cancer
Shinichi Yachida et al.
NATURE (2010)
Advanced pancreatic carcinoma: current treatment and future challenges
Anastasios Stathis et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Identification of MicroRNA-21 as a Biomarker for Chemoresistance and Clinical Outcome Following Adjuvant Therapy in Resectable Pancreatic Cancer
Jin-Hyeok Hwang et al.
PLOS ONE (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma
John P. Morris et al.
NATURE REVIEWS CANCER (2010)
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and-3(v1) trials
J. P. Neoptolemos et al.
BRITISH JOURNAL OF CANCER (2009)
The Role of HuR in Gemcitabine Efficacy in Pancreatic Cancer: HuR Up-regulates the Expression of the Gemcitabine Metabolizing Enzyme Deoxycytidine Kinase
Christina L. Costantino et al.
CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma
Raphael Marechal et al.
CLINICAL CANCER RESEARCH (2009)
Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
James J. Farrell et al.
GASTROENTEROLOGY (2009)
Inhibition of γ-Secretase Activity Inhibits Tumor Progression in a Mouse Model of Pancreatic Ductal Adenocarcinoma
Ruben Plentz et al.
GASTROENTEROLOGY (2009)
Phase III Randomized Comparison of Gemcitabine Versus Gemcitabine Plus Capecitabine in Patients With Advanced Pancreatic Cancer
David Cunningham et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Use of Archived Specimens in Evaluation of Prognostic and Predictive Biomarkers
Richard M. Simon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
The Hedgehog Pathway and Pancreatic Cancer
Manuel Hidalgo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Breaching the Cancer Fortress
Peter Olson et al.
SCIENCE (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Co-evolution of tumor cells and their microenvironment
Kornelia Polyak et al.
TRENDS IN GENETICS (2009)
New treatment options for advanced pancreatic cancer
Gary Middleton et al.
Expert Review of Gastroenterology & Hepatology (2009)
Coordinated epidermal growth factor receptor pathway gene overexpression predicts epidermal growth factor receptor inhibitor sensitivity in pancreatic cancer
Antonio Jimeno et al.
CANCER RESEARCH (2008)
Cancer-associated stroma fibroblasts promote pancreatic tumor progression
Rosa F. Hwang et al.
CANCER RESEARCH (2008)
Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer
G. Feldmann et al.
GUT (2008)
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma - A randomized controlled trial
William F. Regine et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer
Georg Feldmann et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
Sian Jones et al.
SCIENCE (2008)
Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result
Toshio Kurihara et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2008)
Development and characterization of gemcitabine-resistant pancreatic tumor cells
Ami N. Shah et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
A new approach to managing intraductal papillary mucinous pancreatic neoplasms
Paula Ghaneh et al.
GUT (2007)
Targeted agents in the treatment of pancreatic cancer: history and lessons learned
Johanna Bendell et al.
CURRENT OPINION IN ONCOLOGY (2007)
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada clinical trials group
Malcolm J. Moore et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma
Jeffrey R. Infante et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer - A Randomized controlled trial
Helmut Oettle et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling
H Sawai et al.
CANCER RESEARCH (2005)
Expression of glial cell line-derived neurotrophic factor family members and their receptors in pancreatic cancers
Y Ito et al.
SURGERY (2005)
REporting recommendations for tumour MARKer prognostic studies (REMARK)
LM McShane et al.
BRITISH JOURNAL OF CANCER (2005)
Molecular analysis to detect pancreatic ductal adenocarcinoma in high-risk groups
L Yan et al.
GASTROENTEROLOGY (2005)
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
JP Neoptolemos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
BRCA2 germline mutations in familial pancreatic carcinoma
SA Hahn et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
分享论文
